Xie‐an Yu

987 citations
59 papers · 726 indexed · 1 hit paper · h-index 16
Topics
Metabolomics and Mass Spectrometry Studies (9 papers)Chromatography in Natural Products (8 papers)Nanoplatforms for cancer theranostics (7 papers)

In The Last Decade

Xie‐an Yu

56 papers receiving 721 citations

Hit Papers

Recent advances in self-targeting natural product-based n...2025202620255101520

Peers

Xie‐an Yu
Comparison fields: 5 of 89
  • Molecular Biology 335
  • Biomedical Engineering 160
  • Materials Chemistry 121
  • Complementary and alternative medicine 110
  • Plant Science 104
Replace Zhi Sun with:
Zhi Sun China
Yichao Wu China
Guang Hu China
Ying‐Yun Guan China
Zhaoguang Zheng China
Shiyang Zhou China
Tang Li-da China
Zhiguo Hou China
Jiaying Long China
Xie‐an Yu relative to Zhi Sun China Zhi Sun's profile →
Citations per field
00.5×
Zhi Sun · 1×
Citations per year

Countries citing papers authored by Xie‐an Yu

Since Specialization
Citations

This map shows the geographic impact of Xie‐an Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xie‐an Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xie‐an Yu more than expected).

Fields of papers citing papers by Xie‐an Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xie‐an Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xie‐an Yu. The network helps show where Xie‐an Yu may publish in the future.

Co-authorship network of co-authors of Xie‐an Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xie‐an Yu. A scholar is included among the top collaborators of Xie‐an Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xie‐an Yu. Xie‐an Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 14
3
Recent advances in self-targeting natural product-based nanomedicinesbreakdown →
22
4 5
5 6
6 1
7 7
8 3
9 13
10 11
11 7
12 19
13 5
14 16
15 24
16 7
17 16
18 14
19 9
20 31

About Xie‐an Yu

Xie‐an Yu is a scholar working on Nephrology, Complementary and alternative medicine and Biochemistry, having authored 59 papers that have together received 726 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (9 papers), Chromatography in Natural Products (8 papers) and Nanoplatforms for cancer theranostics (7 papers). The work is most often cited by research in Complementary and alternative medicine (110 citations), Pharmacology (76 citations) and Biochemistry (42 citations). Xie‐an Yu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yanxu Chang, Jin Li, Jiangwei Tian, Boyang Yu, Xiumei Gao, Mingrui An, Jun Cao, Jun He, Tiejie Wang and Guo Yin. Their work appears in journals such as PLoS ONE, Analytical Chemistry and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026